Glycogen synthase kinase 3β inhibition as a therapeutic approach in the treatment of endometrial cancer

Authors

Yan Yin, Washington University School of Medicine in St. Louis
Nora T. Kizer, Washington University School of Medicine in St. LouisFollow
Premal H. Thaker, Washington University School of Medicine in St. Louis
Katherine B. Chiappinelli, Washington University School of Medicine in St. LouisFollow
Kathryn M. Trinkaus, Washington University School of Medicine in St. Louis
Paul J. Goodfellow, Washington University School of Medicine in St. LouisFollow
Liang Ma, Washington University School of Medicine in St. Louis

Journal

International Journal of Molecular Sciences

Publication Date

8-12-2013

Volume

14

Issue

8

Inclusive Pages

16617-16637

Document Type

Open Access Publication

DOI

10.3390/ijms140816617

Rights and Permissions

Yan Yin, Nora T. Kizer, Premal H. Thaker, Katherine B. Chiappinelli, Kathryn M. Trinkaus, Paul J. Goodfellow and Liang Ma Article: Glycogen Synthase Kinase 3β Inhibition as a Therapeutic Approach in the Treatment of Endometrial Cancer Int. J. Mol. Sci. 2013, 14(8), 16617-16637; doi:10.3390/ijms140816617

Recommended Citation

Yin, Yan; Kizer, Nora T.; Thaker, Premal H.; Chiappinelli, Katherine B.; Trinkaus, Kathryn M.; Goodfellow, Paul J.; and Ma, Liang, "Glycogen synthase kinase 3β inhibition as a therapeutic approach in the treatment of endometrial cancer." International Journal of Molecular Sciences. 14, 8. 16617-16637. (2013).
https://digitalcommons.wustl.edu/open_access_pubs/1622